Mass Polio Vaccination Drive to Administer More Than 80 Million Doses to Southern African Children in Five Countries 18/03/2022 Raisa Santos Malawi is launching a mass vaccination campaign against wild poliovirus type 1, which is to extend to 23 million children across five southern African countries, WHO said on Friday. The campaign, to kick off Sunday, follows Malawi’s declaration of a polio outbreak on 17 February – three months after the first polio virus case in […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> At Pandemic’s Two Year Milestone: More Investment in the World’s Nurses is Needed – Now 11/03/2022 Howard Catton The applause has long ceased – while the ongoing pressures of the pandemic have left long-term scars on the physical, moral and mental health of the world’s nurses. Two years into the COVID-19 pandemic, governments need to offer better solutions. On 11 March 2020, the World Health Organization (WHO) declared a pandemic, and the world […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> At Pandemic’s Two Year Milestone: More Investment in the World’s Nurses is Needed – Now 11/03/2022 Howard Catton The applause has long ceased – while the ongoing pressures of the pandemic have left long-term scars on the physical, moral and mental health of the world’s nurses. Two years into the COVID-19 pandemic, governments need to offer better solutions. On 11 March 2020, the World Health Organization (WHO) declared a pandemic, and the world […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> At Pandemic’s Two Year Milestone: More Investment in the World’s Nurses is Needed – Now 11/03/2022 Howard Catton The applause has long ceased – while the ongoing pressures of the pandemic have left long-term scars on the physical, moral and mental health of the world’s nurses. Two years into the COVID-19 pandemic, governments need to offer better solutions. On 11 March 2020, the World Health Organization (WHO) declared a pandemic, and the world […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
At Pandemic’s Two Year Milestone: More Investment in the World’s Nurses is Needed – Now 11/03/2022 Howard Catton The applause has long ceased – while the ongoing pressures of the pandemic have left long-term scars on the physical, moral and mental health of the world’s nurses. Two years into the COVID-19 pandemic, governments need to offer better solutions. On 11 March 2020, the World Health Organization (WHO) declared a pandemic, and the world […] Continue reading -> Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Epidemic Coalition Raises $1.5-billion at Summit to Prepare for ‘Disease X’ 08/03/2022 Kerry Cullinan The Coalition for Epidemic Preparedness Innovations (CEPI) raised over $1.5 billion to develop vaccines against emerging diseases in as little as 100 days over the past two days at a pandemic preparedness summit co-hosted by the UK government. CEPI’s total budgetary ask is for $3.5 billion to implement its five-year plan to prepare and protect […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Republic of Korea Named as WHO-Supported Global Training Hub for Manufacturing Vaccines and Biologicals 23/02/2022 Kerry Cullinan The Republic of Korea will serve as the global biomanufacturing training hub for all low- and middle-income countries that want to produce biologicals, including vaccines, insulin, monoclonal antibodies and cancer treatment, the World Health Organization (WHO) announced on Wednesday. Meanwhile, five more countries will also receive support from the WHO-supported global mRNA tech transfer and […] Continue reading -> Posts navigation Older postsNewer posts